Seldenrijk Adrie, Vogelzangs Nicole, Batelaan Neeltje M, Wieman Iris, van Schaik Digna J F, Penninx Brenda J W H
EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
J Psychosom Res. 2015 Feb;78(2):123-9. doi: 10.1016/j.jpsychores.2014.10.007. Epub 2014 Oct 22.
Depression and anxiety are considered etiological factors in cardiovascular disease (CVD), though their relative contribution and differentiation by clinical characteristics have not been studied intensively. We examined 6-year associations between depressive and anxiety disorders, clinical characteristics and newly-developed CVD.
DSM-IV diagnoses were established in 2510 CVD-free participants of the Netherlands Study of Depression and Anxiety. Data on subtype, severity, and psychoactive medication were collected. The 6-year incidence of CVD was assessed using Cox regression analyses adjusted for sociodemographic, health and lifestyle factors.
One-hundred-six subjects (4.2%) developed CVD. Having both current depressive and anxiety disorders (HR=2.86, 95%CI 1.49-5.49) or current depression only (HR=2.30; 95%CI 1.10-4.80) was significantly associated with increased CVD incidence, whereas current anxiety only (HR=1.48; 95%CI 0.74-2.96) and remitted disorders (HR=1.48; 95%CI 0.80-2.75) were not associated. Symptom severity was associated with increased CVD onset (e.g., Inventory of Depressive Symptomatology per SD increase: HR=1.51; 95%CI 1.25-1.83). Benzodiazepine use was associated with additional CVD risk (HR=1.95; 95%CI 1.16-3.31).
Current depressive (but not anxiety) disorder independently contributed to CVD in our sample of initially CVD-free participants. CVD incidence over 6years of follow-up was particularly increased in subjects with more symptoms, and in those using benzodiazepines.
抑郁和焦虑被认为是心血管疾病(CVD)的病因,但其相对贡献以及通过临床特征进行的区分尚未得到深入研究。我们研究了抑郁和焦虑障碍、临床特征与新发生的心血管疾病之间的6年关联。
在荷兰抑郁与焦虑研究中,对2510名无心血管疾病的参与者进行了DSM-IV诊断。收集了关于亚型、严重程度和精神活性药物的数据。使用经社会人口统计学、健康和生活方式因素调整的Cox回归分析评估心血管疾病的6年发病率。
106名受试者(4.2%)发生了心血管疾病。当前同时患有抑郁和焦虑障碍(HR=2.86,95%CI 1.49-5.49)或仅患有当前抑郁(HR=2.30;95%CI 1.10-4.80)与心血管疾病发病率增加显著相关,而仅患有当前焦虑(HR=1.48;95%CI 0.74-2.96)和缓解期障碍(HR=1.48;95%CI 0.80-2.75)则无关联。症状严重程度与心血管疾病发病增加相关(例如,抑郁症状量表每增加一个标准差:HR=1.51;95%CI 1.25-1.83)。使用苯二氮䓬类药物与额外的心血管疾病风险相关(HR=1.95;95%CI 1.16-3.31)。
在我们最初无心血管疾病的参与者样本中,当前的抑郁(而非焦虑)障碍独立导致了心血管疾病。在随访6年期间,症状较多的受试者以及使用苯二氮䓬类药物的受试者的心血管疾病发病率尤其增加。